AltraBio

AltraBio

Paris, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3M

Overview

AltraBio is a Paris-based bioinformatics and data analysis service provider specializing in the oncology and immunology sectors. The company operates as a specialized contract research organization (CRO), using its proprietary AI and statistical platforms to analyze complex biological datasets for its clients. Its core value proposition is automating and scaling expert-level data interpretation, particularly in high-throughput cytometry and omics analysis, thereby freeing up client scientists for higher-value tasks. AltraBio has established a strong reputation, evidenced by testimonials from top-tier pharmaceutical companies and involvement in several major European research consortia.

OncologyImmunology

Technology Platform

A service platform leveraging AI, machine learning, and advanced statistics for the analysis of high-dimensional biological data, specializing in automated cytometry gating, omics analysis, and medical data integration.

Funding History

1
Total raised:$3M
Seed$3M

Opportunities

The rapid growth of single-cell and multi-omics data in drug development creates massive demand for expert analysis.
AltraBio can expand by productizing its successful analytical workflows into scalable software tools and by extending its service model into new therapeutic areas and adjacent industries like dermo-cosmetics.

Risk Factors

Revenue is dependent on a concentrated client base of large pharma companies, creating client concentration risk.
The company faces intense competition from other bioinformatics service providers and internal pharma teams, and must continuously invest in R&D to avoid technological obsolescence.

Competitive Landscape

AltraBio competes with internal bioinformatics teams at pharmaceutical companies, large full-service Contract Research Organizations (CROs), and specialized bioinformatics/ AI analytics startups. Its differentiation lies in its deep expertise in cytometry, its 'production-mode' scalability for large trials, and its reputation for partner-like, high-quality service.